On August 18 2023, the kickoff investigator meeting for a crucial Phase 1b clinical trial for the Schistoshield® schistosomiasis vaccine took place in the Madagascar Institute for Vaccine Research (MIVR), with partners from the Groupe de Recherche Action …
Momentum is building in the Vaccines Against Schistosomiasis for Africa project (VASA)Read More